Hepatitis Monthly

Published by: Kowsar
Corrected Proof scheduled for 18 (6)

A Seroepidemiologic Study of Hepatitis A in Seven to Eighteen-Year-Old School Children in Birjand: New Concerns and Opportunities

Kokab Namakin 1 , Mahmood Zardast 2 , Hadi Naficy 2 and Seyed Alireza Javadinia 3 , *
Authors Information
1 Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Birjand Infections Disease Research Center, Birjand University of Medical Sciences, Birjand, Iran
3 Student Research Committee, Department of Radiation Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Article information

To Cite: Namakin K, Zardast M, Naficy H, Javadinia S A. A Seroepidemiologic Study of Hepatitis A in Seven to Eighteen-Year-Old School Children in Birjand: New Concerns and Opportunities, Hepat Mon. Online ahead of Print ;In Press(In Press):e65966. doi: 10.5812/hepatmon.65966.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
References
  • 1. Ciocca M, Moreira-Silva SF, Alegria S, Galoppo MC, Ruttiman R, Porta G, et al. Hepatitis A as an etiologic agent of acute liver failure in Latin America. Pediatr Infect Dis J. 2007;26(8):711-5. doi: 10.1097/INF.0b013e3180f60bed. [PubMed: 17848883].
  • 2. World Health Organization . World health statistics 2010. World Health Organization; 2010.
  • 3. Quarto M, Chironna M. Hepatitis A Sources in food and risk for health. In: Preedy VR, Watson RR, editors. Reviews in food and nutrition toxicity. Boca Raton, Florida, USA: CRC Press; 2005.
  • 4. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004;132(6):1005-22. doi: 10.1017/S0950268804002857. [PubMed: 15635957]. [PubMed Central: PMC2870191].
  • 5. Jacobsen KH, Koopman JS. The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. Int J Epidemiol. 2005;34(3):600-9. doi: 10.1093/ije/dyi062. [PubMed: 15831565].
  • 6. El-Gilany AH, Hammad S, Refaat K, Al-Enazi R. Seroprevalence of hepatitis A antibodies among children in a Saudi community. Asian Pac J Trop Med. 2010;3(4):278-82. doi: 10.1016/s1995-7645(10)60068-5.
  • 7. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653-7. doi: 10.1016/j.vaccine.2010.08.037. [PubMed: 20723630].
  • 8. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011;11(4):285-8. [PubMed: 22706273]. [PubMed Central: PMC3206696].
  • 9. Tsou TP, Liu CC, Huang JJ, Tsai KJ, Chang HF. Change in hepatitis A epidemiology after vaccinating high risk children in Taiwan, 1995-2008. Vaccine. 2011;29(16):2956-61. doi: 10.1016/j.vaccine.2011.02.001. [PubMed: 21329774].
  • 10. Nokhodian Z, Ataei B, Babak A, Yaran M, Pahlevani A. Seroprevalence of Hepatitis A among Street Children, Isfahan, Iran. J Isfahan Med Sch. 2012;30(178):1-7.
  • 11. Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ. 2001;165(3):293-7. [PubMed: 11517645]. [PubMed Central: PMC81329].
  • 12. Roy E, Haley N, Leclerc P, Cedras L, Bedard L, Allard R. Seroprevalence and risk factors for hepatitis A among Montreal street youth. Can J Public Health. 2002;93(1):52-3. [PubMed: 11925701].
  • 13. Wasley A, Feinstone SM, Bell BP. Hepatitis A Virus. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 7 ed. Philadelphia, PA: Churchill Livingstone; 2010. p. 2367-87. doi: 10.1016/b978-0-443-06839-3.00173-9.
  • 14. Saffar MJ, Saffar H, Saffar H. [Viral hepatitis and prevention-current status and future prospects]. J Mazandaran Univ Med Sci. 2008;18(67):133-44. Persian.
  • 15. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med. 1996;150(7):733-9. doi: 10.1001/archpedi.1996.02170320079014. [PubMed: 8673200].
  • 16. Alian S, Ajami A, Ghasemian R, Yadegarinia D. Age-specific seroprevalence of hepatitis A in Sari, northern Islamic Republic of Iran. East Mediterr Health J. 2011;17(10):754-8. doi: 10.26719/2011.17.10.754. [PubMed: 22256409].
  • 17. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004;19(3):275-8. [PubMed: 15117123].
  • 18. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Etemadi G, Azad-Armaki S, et al. Seroepidemiology of hepatitis A virus in children of different age groups in Tehran, Iran: implications for health policy. Travel Med Infect Dis. 2010;8(3):176-9. doi: 10.1016/j.tmaid.2010.02.004. [PubMed: 20541138].
  • 19. Ziaee M, Ebrahimzadeh A, Azarkar Z, Namaei MH, Saburi A, Fereidouni M, et al. Seroprevalence and Risk Factors for Hepatitis B in an Adult Population: The First Report from Birjand, South Khorasan, Iran. Hepat Mon. 2016;16(9). e36452. doi: 10.5812/hepatmon.36452. [PubMed: 27822260]. [PubMed Central: PMC5090805].
  • 20. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2010;29(3):160-2.
  • 21. Ataei B, Nokhodian Z, Javadi AA, Kasaeyan N, Farajzadegan Z, Shoaei P. [Seroepidemiology of Hepatitis A virus Infections in over 6-years population in Isfahan, Iran: A community-based study]. J Isfahan Med Sch. 2008;25(86):53-46. Persian.
  • 22. Mohebbi SR, Rostami Nejad M, Tahaei SM, Pourhoseingholi MA, Habibi M, Azimzadeh P, et al. Seroepidemiology of hepatitis A and E virus infections in Tehran, Iran: a population based study. Trans R Soc Trop Med Hyg. 2012;106(9):528-31. doi: 10.1016/j.trstmh.2012.05.013. [PubMed: 22835757].
  • 23. Taghavi Ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran. Hepat Mon. 2013;13(5). e10553. doi: 10.5812/hepatmon.10553. [PubMed: 23967019]. [PubMed Central: PMC3741904].
  • 24. Saffar MJ, Abedian O, Ajami A, Abedian F, Mirabi AM, Khalilian AR, et al. Age-specific seroprevalence of anti-hepatitis a antibody among 1-30 years old population of savadkuh, mazandaran, iran with literature review. Hepat Mon. 2012;12(5):326-32. doi: 10.5812/hepatmon.6035. [PubMed: 22783344]. [PubMed Central: PMC3389358].
  • 25. Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015;15(12). e35238. doi: 10.5812/hepatmon.35238. [PubMed: 26977171]. [PubMed Central: PMC4779254].
  • 26. Moradi-Lakeh M, Esteghamati A. National Immunization Program in Iran: whys and why nots. Hum Vaccin Immunother. 2013;9(1):112-4. doi: 10.4161/hv.22521. [PubMed: 23442584]. [PubMed Central: PMC3667923].
  • 27. Hoseini SG, Kelishadi R, Ataei B, Yaran M, Motlagh ME, Ardalan G, et al. Seroprevalence of hepatitis A in Iranian adolescents: is it time to introduce a vaccine? Epidemiol Infect. 2016;144(2):291-6. doi: 10.1017/S0950268815001302. [PubMed: 26083105].
  • 28. Sacy RG, Haddad M, Baasiri G, Khoriati A, Gerbaka BJ, Abu-Elyazeed R. Hepatitis a in Lebanon: a changing epidemiological pattern. Am J Trop Med Hyg. 2005;73(2):453-6. [PubMed: 16103621].
  • 29. Mostafavi N, Kelishadi R, Kazemi E, Ataei B, Yaran M, Motlagh ME, et al. Comparison of the Prevalence and Risk Factors of Hepatitis A in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The CASPIAN-III Study. Hepat Mon. 2016;16(9). e36437. doi: 10.5812/hepatmon.36437. [PubMed: 27822259]. [PubMed Central: PMC5091029].
  • 30. Ghasemian R, Babamahmoodi F, Ahangarkani F. Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report. Hepat Mon. 2016;16(6). e38138. doi: 10.5812/hepatmon.38138. [PubMed: 27630729]. [PubMed Central: PMC5011296].
  • 31. Safiabadi M, Rezaee-Zavareh MS, Moayed Alavian S. Estimation of hepatitis A virus infection prevalence among Eastern Mediterranean and Middle Eastern Countries: a systematic review and pooled analysis. Hepat Mon. 2017;17(2). doi: 10.5812/hepatmon.44695.
  • 32. Averhoff F, Shapiro CN, Bell BP, Hyams I, Burd L, Deladisma A, et al. Control of hepatitis A through routine vaccination of children. JAMA. 2001;286(23):2968-73. doi: 10.1001/jama.286.23.2968. [PubMed: 11743837].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments